account_balance
Investment manager · 13F filer · SEC CIK 1224962
Perceptive Advisors LLC
Reported value$6.44Bas of Jun 30, 2026
Positions102 23 new, 13 sold out
Top 10 weight48.9%PRAX alone is 11%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
PRAXPraxis Precision Medicines I
10.6%
SYRESpyre Therapeutics Inc
6.0%Added +14%
CELCCelcuity Inc
5.2%Added +2%
ASNDAscendis Pharma A/s
4.8%New
RYTMRhythm Pharmaceuticals Inc
4.5%Added +9%
ROIVRoivant Sciences Ltd
4.4%Trimmed −2%
RLAYRelay Therapeutics Inc
4.1%Added +45%
TVTXTravere Therapeutics Inc
3.3%Trimmed −9%
KARDKardigan Inc
3.0%New
NUVLNuvalent Inc
3.0%
EWTXEdgewise Therapeutics Inc
2.8%
APGEApogee Therapeutics Inc
2.7%Trimmed −15%
PRAXPraxis Precision Medicines I
10.6%
SYRE6.0%CELCCelcuity Inc
5.2%Added +2%
ASNDAscendis Pharma A/s
4.8%New
RYTMRhythm Pharmaceuticals Inc
4.5%Added +9%
ROIV4.4%RLAY4.1%TVTX3.3%KARD3.0%NUVL3.0%
EWTX2.8%APGE2.7%
Boxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
PRAX Praxis Precision Medicines I 10.6% HeldSYRE Spyre Therapeutics Inc 6.0% Added +14%CELC Celcuity Inc 5.2% Added +2%ASND Ascendis Pharma A/s 4.8% NewRYTM Rhythm Pharmaceuticals Inc 4.5% Added +9%ROIV Roivant Sciences Ltd 4.4% Trimmed −2%RLAY Relay Therapeutics Inc 4.1% Added +45%TVTX Travere Therapeutics Inc 3.3% Trimmed −9%KARD Kardigan Inc 3.0% New
NUVL Nuvalent Inc 3.0% Held
EWTX Edgewise Therapeutics Inc 2.8% HeldAPGE Apogee Therapeutics Inc 2.7% Trimmed −15%
What changed
Biggest moves since Mar 31, 2026
remove_circleSold out
- Ascendis Pharma A/s $350M
- Centessa Pharmaceuticals PLC $209M
- Engene Holdings Inc $39.7M
- Day One Biopharmaceuticals I $37.6M